Condition:   Rheumatoid Arthritis
Interventions:   Drug: MP-435(dose1) + Methotrexate;   Drug: Placebo + Methotrexate
Sponsor:   Mitsubishi Tanabe Pharma Corporation
Recruiting - verified August 2011